Transluminal delivery of oncoltyic viruses for cancer therapy
US9675673B2 · kind B2 · utility
0Cited by
8References
13Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 23, 2010 |
| Grant date | Jun 13, 2017 |
| Priority date | — |
| Expiry date | Sep 12, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14332
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods, apparatus and compositions are provided for treatment of cancer of a selected organ by intraluminal delivery of oncolytic agents through a blood vessel or duct leading to the cancer tissue. During the time the oncolytic agents are being applied to the targeted tissue downstream, the designated vessel or duct can be selectively occluded to increase concentration and pressure of the applied agents at the target site. Oncolytic compositions including oncolytic viruses formulated with delivery visualization markers are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.